Leadership
Our leadership, including the management team and Board of Directors, is made up of venture capital investing, AI technology, biotechnology and pharmaceutical industry experts who are recognized for their contributions to discovering and developing new therapies and their track record of successfully bringing creating and managing AI-Enabled drug discovery startups.
Greg Getten
Co-Founder, Chairman
Hentabli Hamza PhD
Co-Founder, Chief Technology Officer
Sehrish Naz, PhD
Chief Operating Officer
Henry Yu, PhD
General Manger – Asia Pacific
Board Members & Advisors
Pamela Garzone, PhD
Board Member
Daniel Kwong
Board Advisor
Girinath Pillai, PhD
Board Advisor
Rick Sayegh, MD, MBA
Medical Advisor
Raymond Choo, PhD
Technical Advisor
Henok G. Woldu, PhD
Technical Advisor